1
Iron and Infections by Protozoa*
João Pedro Oliveira Morgado Madaíl1,2
1Faculdade de Medicina da Universidade de Coimbra
2Médico Interno de Patologia Clínica no Hospital Curry Cabral (Lisboa)
E-mail address: [email protected]
Resumo
O ferro, um elemento essencial para quase todos os organismos vivos, constitui um desafio
nas interacções entre o hospedeiro e os patogénios infecciosos. Esta revisão sumariza as
características mais importantes no que diz respeito ao metabolismo do ferro e à sua regulação
no corpo humano e analisa como o ferro pode afectar a interacção do hospedeiro humano com
alguns protozoários patogénicos.
O metabolismo do ferro deve ser eficazmente regulado para alcançar um equilíbrio
necessário para a saúde, inclusive para uma imunidade eficiente. A contínua descoberta e
caracterização de várias vias envolvidas no metabolismo do ferro e na sua regulação têm
contribuído para a nossa compreensão desta área. A recente descoberta da hepcidina, o
regulador-chave do metabolismo do ferro num contexto sistémico, é um exemplo deste facto.
Alguns protozoários são causas importantes de morbidade e de mortalidade e uma
estratégia de defesa importante do nosso organismo apoia-se na redução da disponibilidade do
ferro, a nível intra e extracelular, para estes parasitas. Assim, a aquisição de ferro pode
2
constituir um desafio para os protozoários patogénicos, que serão tanto mais virulentos quanto
mais capazes forem de superar os obstáculos e satisfazer as suas necessidades em relação a
este elemento. A investigação nesta área está a revelar alvos possíveis e estratégias para
desenvolver novos tratamentos / medicamentos.
É necessária mais investigação para completar o “puzzle” do metabolismo do ferro no
organismo humano e para caracterizar melhor a importância do ferro nas infecções por
protozoários.
Palavras-chave: ferro, protozoário, infecção, macrófago, anemia
* Trabalho Final no âmbito do Ciclo de Estudos de Mestrado Integrado em Medicina com
vista a atribuição do grau de Mestre em Medicina
Abstract
Iron, an essential element for almost all living organisms, constitutes a challenge in host –
infectious pathogen interactions. This review summarizes the most important features
concerning iron metabolism and its regulation in the human body and analyzes how iron can
affect the interaction of the human host with some protozoan pathogens.
. Iron metabolism must be tightly regulated to achieve an equilibrium necessary for the health,
including for an efficient immunity. The continued discovery and characterization of several
pathways involved in iron metabolism and in its regulation have contributed to our
understanding of this field. The recent discovery of hepcidin, the key regulator of iron
metabolism in a systemic context, is an example of this.
Some protozoans are important causes of morbidity and mortality and an important defense
strategy of our organism rely on the reduction of iron availability, at intra and extracellular
levels, to these parasites. So, iron acquisition can be a challenge to protozoan pathogens that
3
will be the more virulent the more able they are to overcome obstacles and satisfy their needs
regarding this element. Research on this area is revealing possible targets and strategies to
develop new treatments / drugs.
Further research is needed to complete the puzzle of iron metabolism in the human body
and to better characterize the importance of iron in protozoan infections.
Keywords: iron, protozoan, infection, macrophage, anemia
Introduction
Iron is an essential element for virtually all living organisms, being responsible for several
functions in the human body (Table 1).
Table 1 – Main Functions of Iron in the Human Body
Energy Metabolism (as a constituent of oxygen transporters and of enzymes involved in the
respiratory chain)
Immunity (affects proliferation and differentiation of immune cells and modulates their anti-
microbial effector pathways)
DNA synthesis and regulation of transcription (as a central component of ribonucleotide
reductase or by modulating the binding affinities of central transcription factors via its
catalyzing role for radical processes)
Myelin and neurotransmitter synthesis
Collagen formation
I
The metabolism of this element in the human body is complex. Because of inherent
technical difficulties and ethic concerns in studying the subject in the human organism a
4
significant part of present knowledge is inferred from intensive research in vitro and in
murine models. The same is applicable when protozoan infections are studied.
Protozoan infections, such as malaria or visceral leishmaniasis, are important causes of
morbidity and mortality. Research on iron has contributed to the understanding of the
pathology of at least some of these infections and has suggested possible targets and strategies
for their treatment.
Iron Metabolism in the Human Body
The Iron Cycle
Intake
Iron (Fe) is usually acquired from the diet through intestinal absorption (mainly in
duodenum) (Fauci et al., 2008; Friedman et al., 2009). It is estimated that, in healthy
individuals with a balanced diet, iron is absorbed mainly in its hemic form (West and Oates,
2008). This is because hemic iron is more bioavailable than non-heme iron (Nadadur et al.,
2008; Edison et al., 2008). However, in certain pathologies such as iron deficiency anemia,
iron can also be acquired through transfusions and / or through iron supplementation either
oral or intravenous (Andrews 2008; Fauci et al., 2008). In contrast, iron losses occur passively
through the bile and small blood losses as well as through removal of epidermic cells and
enterocytes (Knutson and Wessling-Resnick, 2003).
5
In normal circumstances, the daily iron needs are satisfied by the reuse of this metal in the
organism, dietary iron contributing only in a small proportion (usually 1-2mg) to compensate
passive losses (Swinkels et al., 2006; Kemna et al., 2008).
Non-heme iron enters to the enterocyte through the divalent metal transporter 1 (DMT1)
(Rhodes and Ritz, 2008). For this, ferric iron (Fe3+
) must be first reduced to ferrous iron (Fe2+
)
either chemically or through the activity of a brush border ferrireductase probably the
duodenal cytochrome B (DcytB) or members of the six-transmembrane epithelial antigen of
the prostate (STEAP) family (Andrews, 2008; Rhodes and Ritz, 2008). Once in the
enterocyte, iron becomes part of the intracellular calcein-chelatable iron pool (ICIP) from
where it can be utilized for cellular metabolism, be stored as ferritin, or be transported to the
plasma by the 62 kDa exporter ferroportin (FPN) (Nadadur et al., 2008; Friedman et al.,
2009). Plasma iron is bound by the 80 kDa serum glycoprotein transferrin (Tf), after oxidation
of Fe2+
to Fe3+
by the ferroxidase hephaestin (Swinkles et al., 2006; Nadadur et al., 2008).
There is an additional mucin-integrin mobilferrin pathway for iron uptake, which is less
understood (Edison et al., 2008; Nadadur et al., 2008).
Heme iron absorption is poorly understood and there are two main accepted hypothesis on
this subject, namely via receptor mediated endocytosis and through heme transporters (West
and Oates, 2008). The last hypothesis is more recent and suggests that heme is internalized
through a proton-coupled folate transporter / heme carrier protein 1 (PCFT/HCP1) directly
into the cytoplasm of the enterocyte. From there it can be transported across the basolateral
membrane by the feline leukemia virus subgroup C cellular receptor (FLVCR) to bind the
plasma glycoprotein hemopexin, or be catabolised to non-heme iron, carbon monoxide (CO)
and biliverdin by heme oxygenase 1 (HO-1) located on the endoplasmic reticulum or even by
HO-2. The other hypothesis suggests that heme iron is internalized via receptor mediated
6
endocytosis with subsequent degradation by HO-2 inside vesicles, being the resulting metal
released to the cytosol by DMT-1. It is also hypothesized that the heme iron absorption rate is
limited by heme degradation through HO which activity is highest in duodenum (West and
Oates, 2008). Any iron released from heme inside the enterocyte can be transported by FPN to
the bloodstream in the same way as non-heme iron (Andrews, 2008; West and Oates, 2008;
Edison et al., 2008).
Iron transport and its uptake and utilization by the cells
In our organism, the majority of iron does not exist as free iron. Extracellular iron exists
mainly as Tf and lactoferrin (Lf) in serum or at mucosal surfaces respectively (Wilson and
Britigan, 1998). As occurs with Lf, one mol of Tf binds two mol of iron (Wilson and Britigan,
1998; Edison et al., 2008). In fact, Tf has two binding sites for Fe3+
, at the C-terminal and N-
terminal of the protein, but iron binding in serum occurs mainly in the latter because it is more
acid-labile (Wilson and Britigan, 1998). Production of Tf occurs mainly in hepatocytes but it
can also be generated in other cells such as Sertoli cells (Andrews, 2008). The Tf-Fe complex
(holotransferrin) is endocytosised by cells expressing transferrin receptors (TfR) at their
surface, diferric Tf possessing the highest affinity for these receptors (Andrews, 2008; Skikne,
2008). There are two types of TfR: TfR1 and TfR2. The latter, discovered more recently, is
highly expressed in the liver and in some proliferating cells and has lower affinity for Tf than
TfR1, which is the main Tf-Fe3+
receptor and is expressed in almost all cells (except in mature
erythrocytes) (Taketani, 2005; Rhodes and Ritz, 2008; Nadadur et al., 2008).
Endocytosis of holotransferrin, via clathrin-coated pits to an acidic endosome, is the usual
pathway for iron acquisition by many cells, specially by erythroblasts and other rapidly
dividing cells (Figure 1) which express a great number of TfR1 (Andrews, 2008; Friedman et
al., 2009). At the low pH of the endosome, Fe3+
is released and reduced to Fe2+
by a Steap
7
family member (STEAP3) or by another ferric reductase (such as cytochrome b reductase 1)
so that it can be transported to the cytosol through DMT1 (Knutson and Wessling-Resnick,
2003; Taketani, 2005; Rhodes and Ritz, 2008). This bioavailable iron will be used in cellular
metabolism (where the mitochondria plays an important role), for example in the synthesis of
hemoglobin (Hb) and other proteins, while the endocytosis complex (apoTf plus TfR) is
recycled to the cell surface (Rhodes and Ritz, 2008; Sackman et al., 2009; Friedman et al.,
2009).
Figure 1. Main iron uptake pathway in cells (such as the erythroblast). TfR1 binds holo-Tf and
the resulting complex suffers endocytosis. In the acidic environment of the endosome, Fe3+
is released
and subsequently reduced to be transported to the cytosol by DMT1 while Tf-TfR is recycled to the
cell surface. In the cytosol, Fe2+
will be used in cellular metabolism (for example: Hb synthesis).
8
Excess of iron, that is, iron not used for cellular metabolism, can be stored in the cytosol,
as ferritin (Weinberg, 2008; Fauci et al., 2008). Ferritin is a water soluble protein comprised
of 24 light (L) and heavy (H) chain subunits in varying ratios, resulting in a hollow ball that
can hold up to 4500 Fe3+
(Andrews, 2008; Edison et a., 2008) . Liver and spleen are rich in L
subunits in contrast to the heart and the kidney that are rich in H subunits (Northrop-Clewes,
2008). H-ferritin presents ferroxidase activity and is slightly larger than L-type (Andrews,
2008; Northrop-Clewes, 2008). In order to be stored inside ferritin, Fe2+
must reach the
ferroxidase centers in the protein cavity where Fe3+
is formed. This may occur by facilitated
diffusion through 3-fold hydrophilic channels (Bou-Abdallah et al., 2008). Whenever iron is
required, ferritin may undergo hydrolysis. This is a characteristic present, for example, in the
liver, which contributes to recirculation of iron (Edison et al., 2008).
Mitochondria is an important cellular organelle. It is essential for energy metabolism,
participates in heme and iron-sulfur cluster biosynthesis and also in iron metabolism, a
process still not fully understood. In contrast to lysosomes, the amount of iron in
mitochondria does not seem to respond to the cell iron in status (Taketani, 2005).
Nevertheless, the enzyme ferrochelatase, that enters in the final step of heme biosynthesis, is
referred to as being an iron sensor in mitochondria (Taketani, 2005).
Iron import from the cytosol to mitochondria is facilitated by endosomes that come in
contact with this organelle and also through mitochondrial iron importers, mitoferrins (Edison
et al., 2008; Paradkar et al., 2009). Pump proteins ABC7 (ATP-binding cassette 7) and
MTABC3 (mammalian mitochondrial ABC protein 3) are involved in mitochondrial iron
export; ABC7, as Taketani S. (2005) concluded, “plays a role in the maturation of
mitochondrial iron-sulfur-containing proteins, in addition to cytosolic iron-sulfur-containing
proteins” and the mitochondrial transporter ABC-me (ABC-mitochondrial erythroid) also
9
promotes Hb synthesis and erythroid differentiation (Taketani, 2005). The mitochondrial
matrix protein frataxin increases the bioavailability of Fe essential for Fe-S cluster and heme
biosynthesis and mitochondrial ferritin (Mt-ferritin), which is homologous to the H chain of
the cellular ferritin, acts as the organelle iron storage site playing a protective role against iron
mediated toxicity inside this cell compartment (Taketani, 2005; Edison et al., 2008). GTP may
also participate in mitochondrial iron homeostasis (Edison et al., 2008).
Cells of the reticuloendothelial system (RES) are of major importance in iron metabolism.
They phagocyte senescent red blood cells and, together with the hepatic parenchyma, are the
main storage sites for iron (Weiss, 2005; Theurl et al., 2005; Edison et al., 2008). When the
erythrocyte is phagocytized, Hb undergoes proteolysis in the phagolysosome, originating
heme that probably migrates to the endoplasmic reticulum (ER) to be catabolysed by HO-1
(Knutson and Wessling-Resnick, 2003). Nevertheless, the exact site for heme catabolism and
the existence and characterization of relevant heme transporters need to be clarified (Knutson
and Wessling-Resnick, 2003). Fe resulting from red blood cells catabolism is either stored in
the cell or exported to plasma via FPN (which is also present in other iron exporting cells such
as the already referred enterocytes as well as placental syncytiotrophoblast and hepatocytes),
although 10-20% will remain as part of the labile iron pool, which is important for cellular
functions as well for regulation of cellular iron homeostasis (Theurl et al., 2005; Schaer et al.,
2008; Fleming, 2008). The recycling process resulting from erythrophagocytosis will satisfy
the majority of daily iron needs (Knutson and Wessling-Resnick, 2003; Fauci et al., 2008).
Cells from the RES can also acquire iron through other ways. The receptor CD163, which
is present in monocytes and macrophages, participates in the clearance of Hb-haptoglobin
complexes from the circulation (Taketani, 2005; Theurl et al., 2005; Edison et al., 2008). This
receptor might also remove free Hb, resulting from normal or increased intravascular
10
hemolysis or from erythrocyte disruption during erythrophagocytosis (Knutson and Wessling-
Resnick, 2003; Schaer et al., 2006; Schaer et al., 2008). CD163 is recycled to the cell surface
after internalization, which improves Hb clearance (Schaer et al., 2006). Genetic
polymorphisms in haptoglobin seem to have a role in this uptake process because it was found
that the multimeric Hp2-2 phenotype has the highest functional affinity for CD163 (Knutson
and Wessling-Resnick, 2003). RES cells also possess specific hemopexin receptors which
may constitute a way for clearance of heme resulting from intravascular degradation of Hb
(and exported by the enterocytes through FLVCR?) (Knutson and Wessling-Resnick, 2003;
West and Oates, 2008). Inside the cell, Hb and/or heme will be catabolized (the last one by
HO-1) with subsequent release of iron (Schaer et al.. 2008). In a study with human
macrophages, Schaer et al. (2008) detected HCP-1 within early endosomes of the CD63 Hb
uptake pathway, which suggests that it can transport some of the heme released from Hb in
these vesicles to the cytosol; it was also observed traffic of Hb-haptoglobin complexes
through the endosomal compartment to lysosomes where a possible heme exporter remains
unknown. Macrophages also express on their surface TfR1 and receptors for Lf. In addition
there is also experimental evidence for Lf re-circulation (Theurl et al., 2005; Das et al., 2009).
Glyceraldehyde-3-phosphate dehydrogenase is present on the macrophage cell surface where
it act as a TfR and which expression is increased by iron depletion (Edison et al., 2008).
As indicated above, the RES is of vital importance in iron storage. In this process, ferritin
is of fundamental importance as is its insoluble and partially digested form, hemosiderin,
which concentration in these cells is the highest in the body thus facilitating larger deposits of
intracellular iron (Knutson and Wessling-Resnick, 2003).
Iron release from RES cells occurs in a poorly understood circadian rhythm and it seems
that neither Tf nor its iron-binding capacity are essential for this release, in contrast to the
11
multicopper ferroxidase ceruloplasmin, which oxidizes Fe2+
to Fe3+
enabling iron binding to
apoTf (Knutson and Wessling-Resnick, 2003). Although most of the iron released into the
plasma will bind Tf, macrophages can also release iron in the form of Hb, heme and ferritin
(Knutson and Wessling-Resnick, 2003).
Like macrophages, hepatocytes can also acquire iron via multiple pathways, for example
through hemopexin receptors and TfR, but they must be better elucidated (Knutson and
Wessling-Resnick, 2003; Swinkels et al., 2006; Edison et al., 2008).
Lymphocytes, key cells in specific immunity, require iron in order to differentiate and
proliferate. These cells are more dependent on the Tf/TfR pathway than monocytes /
macrophages (Weiss, 2005). B cells seem to be less sensitive than T cells to modifications in
iron homeostasis and a similar comparison can be drawn between Th1 and Th2 cells, where
the first are more sensitive (Weiss, 2005; Theurl, 2005). H-ferritin receptors as well as Lf
receptors can also be expressed by lymphocytes, but their exact functions need to be better
elucidated (Weiss, 2005).
In what concerns the central nervous system (CNS), transport of iron across the blood
brain barrier is mediated either by Tf or by Lf-, melanotransferrin- and H-ferritin endo- and/or
transcytosis (Rhodes and Ritz, 2008). In this system, ferritin is expressed mainly in
oligodendrocytes, astrocytes and, specially, in microglia (Rhodes and Ritz, 2008).
Nevertheless, some particular aspects of iron metabolism in CNS are an open field and need
further research.
During pregnancy, the growing fetus requires large amounts of iron, which are acquired
from maternal blood. So, Fe is actively transported against a gradient across the
syncytiotrophoblast that expresses TfR1 on the maternal surface and FPN on the fetal surface
12
(Friedman et al., 2009). Fe will eventually be incorporated in fetal Tf but these mechanisms
are still poorly understood (Friedman et al., 2009).
Regulation of Iron Metabolism
In order to keep our organism healthy, iron homeostasis must be ensured. This permits the
necessary stores of iron required for life to be maintained in a form that avoids the inherent
toxicity of Fe2+
. This arises from the formation of oxygen free radicals by the Fenton reaction
and can damage cell membranes, proteins and nucleic acids (Andrews, 2008; Edison et al.,
2008). One effective way to maintain iron non-reactive is through its chelation to proteins,
mainly Tf and ferritin (as discussed before). Heme can also damage cell structures because it
is a pro-oxidant and a strategy to prevent its toxicity is the induction of HO-1 expression, the
rate-limiting enzyme in heme catabolism, by various stimuli (including Hb-CD163 in
monocytes and macrophages) (Schaer et al., 2006; West and Oates, 2008).
As referred before, our organism has no regulated pathway to eliminate iron, so, its balance
is primarily controlled at duodenal absorption and through storage and recycling mechanisms
(Nadadur et al., 2008; Subramaniam, 2009).
Iron requirements in bone marrow are an important factor in the physiological regulation
of iron release from the RES (Knutson and Wessling-Resnick, 2003).
In adverse circumstances leading to iron deficiency, such as hemorrhage, dietary
deficiency or inadequate duodenal absorption, a significative quantity of iron can be
mobilized from the stores (Fauci et al, 2008). Iron deficiency also leads to an increase in heme
and non-heme iron absorption as well in HO activity in duodenum, but heme absorption
cannot be upregulated to the same extent as non-heme iron (West and Oates, 2008).
13
Cellular level
Intracellular iron homeostasis is controlled through several mechanisms. An important one
occurs at the post-transcriptional level through the interaction between the iron regulatory
proteins (IRP) 1 and 2 with iron responsive elements (IRE) present on mRNAs of genes
involved in cellular iron metabolism (Knutson and Wessling-Resnick, 2003; Edison et al.,
2008). In vivo studies reported that, apparently, only inactivation of the IRP2 gene produced
phenotypic abnormalities (such as microcytic hypochromic anemia); however inactivation of
both genes is incompatible with life, which demonstrates the vital importance of this system
(Andrews, 2008). Nevertheless IRP-IRE interactions need to be better elucidated in vivo
(Nadadur et al., 2008).
At high Fe levels, IRP-1 displays aconitase activity and, in contrast, at low Fe levels, it
binds IREs and loses its 4Fe-4S cluster, which leads to the loss of aconitase activity
(Andrews, 2008; Dos Santos et al., 2008). Reactive oxygen species, serine phosphorylation,
nitric oxide (NO) and hypoxia can also affect the regulation of this protein (Edison et al.,
2008). Additionally, IRP-1 is quickly degraded when binds heme irreversibly (Taketani,
2005).
IRP-2 does not show aconitase activity and has a 73 amino acids (aa) iron-degradation
domain (IDD). This IRP is degraded in proteosomes, except when Fe levels are low in which
situation it binds to IREs, in an IDD-dependent fashion (Taketani, 2005). NO and hypoxia
also affect IRP2 (Edison et al., 2008)
IREs are present at the 5’UTRs of ferritin, FPN and e-ALAS (erythroid amino levulinic
acid synthase, the enzyme responsible for the first step of heme biosynthetic pathway)
mRNAs (Theurl et al., 2005). The 3’UTR of TfR1 mRNA possesses five IREs and the 3’UTR
14
of DMT1 a single IRE (Dos Santos et al., 2008). IRE-like structures were also found in other
mRNAs not directly related to iron metabolism such as the case of alpha Hb stabilizing
protein (AHSP) mRNA (Dos Santos et al., 2008).
When cytoplasmic Fe is low, IRPs bind IREs, increasing the stability of TfR1 and DMT1
mRNAs and decreasing the translation of ferritin, FPN and e-ALAS genes, which will
enhance iron uptake by the cell and reduce its storage and exportation (Rhodes and Ritz,
2008; Nadadur et al., 2008). The inverse occurs when Fe levels are high: IRPs separate from
IREs, which facilitates TfR and DMT1 mRNAs degradation by nucleases and iron storage in
ferritin (Taketani, 2005; Rhodes and Ritz, 2008).
Other mechanisms than the IRE/IRP interactions have been reported and hypothesized. For
example, in the case of TfR2, its mRNA has no IRE (Taketani, 2005) and, so, other factors
may be involved. TfR1 expression at the cell surfaces is also regulated at the transcriptional
level through the status of cellular proliferation and oxygen saturation (Sackmann et al.,
2009). HFE may also modulate the transferrin-dependent iron uptake by forming a
stoichiometric complex with TfR1, thus reducing the affinity of the receptor for Tf (Taketani,
2005; Theurl et al., 2005). In inflammatory conditions, cellular iron homeostasis can be
modified by several cytokines (Edison et al., 2008; Northrop-Clewes, 2008).
The vital role of Hepcidin
Hepcidin, the key regulator of systemic iron metabolism, is a 25aa cationic peptide
hormone, produced mainly by the liver, but also by macrophages, monocytes, fat cells,
kidney, spinal cord, myeloid cells and cardiomyocytes (Collins et al., 2008; Schulze et al.,
2008; Huang et al., 2008). After its secretion into the circulation, hepcidin is filtered by the
kidney and detected in urine (Collins et al., 2008; Fleming, 2008).
15
The hepcidin gene (HAMP) is located on chromosome 19q13.1 and encodes the 84 aa pre-
prohepcidin, which undergoes a first enzymatic cleavage of a 24aa amino-terminal
endoplasmic reticulum - targeting signal peptide originating the 60aa prohepcidin (Swinkels
et al., 2006; Collins et al., 2008). Remotion of the 35aa proregion of prohepcidin by a furin-
like proprotein convertase leads to mature hepcidin (Huang et al., 2008). Pre-prohepcidin can
also be secreted into the circulation, where its stepwise conversion into mature hepcidin can
also occur (Huang et al., 2008).
Hepcidin decreases ferremia by interaction with FPN and some studies also indicate that
this hormone negatively regulates DMT1 and DcytB (Howard et al., 2007; Nadadur et al.,
2008). When hepcidin binds to aa 324-343 on an extracellular loop of FPN, it triggers FPN
tyrosine phosphorylation [mediated by Janus kinase 2 (JAK2)] with consequent
internalization through clathrin-coated pits and ubiquitin-mediated degradation in lysosomes
(Collins et al., 2008; Friedman et al., 2009; Subramaniam, 2009). This inhibits duodenal and
macrophage iron export and iron mobilization from hepatic stores (Collins et al., 2008; Huang
et al; 2008). Hepcidin is also a negative regulator of placental transport of iron to the fetus,
with an accumulation of iron in trophoblast cells (Edison et al., 2008; Friedman et al., 2009).
Iron status is an important factor for the expression of hepcidin, even in pregnancy
(Schulze et al., 2008). The expression of this hormone is enhanced in iron overload conditions
and is suppressed in iron deficiency (Rhodes and Ritz, 2008; Schulze et al., 2008). In
addition, its expression is also decreased by hypoxia and erythropoiesis and is elevated by
inflammation (Andrews, 2008; Collins et al., 2008).
There are a number of pathways that regulate hepcidin expression. The bone
morphogenetic protein / sons of mothers against decapentaplegic homologue (BMP/SMAD)
pathway is a main activator of hepcidin transcription not completely understood, specially in
16
response to body iron stores (Fleming, 2008; Kemna et al., 2008).
In this pathway,
hemojuvelin (HJV), a glycosylphosphoinositide (GPI) - linked cell surface protein, that is
expressed in hepatocytes and in skeletal and cardiac muscles, acts as a BMP coreceptor and it
seems that SMADs will bind directly to the hepcidin promoter (Andrews, 2008; Fleming,
2008). The competition between HFE and holoTf in binding to TfR1 promotes the formation
of the TfR2/HFE complex which induces hepcidin production (Kemna et al., 2008; Edision et
al., 2008). Also, hepcidin transcription is induced by IL-6, a cytokine involved in the acute
phase response, through binding of the signal transducer and activator of transcription 3
(STAT 3) protein to the promoter region of this hormone (Fleming, 2008; Rhodes and Ritz,
2008). This modulation on hepcidin transcription in inflammatory conditions needs SMAD4
to STAT3 activation and may be strong enough to induce hepcidin release even in a context
of anemia, although this subject must be better elucidated when all the regulatory pathways of
hepcidin and their interactions are well understood (Nadadur et al., 2008; Oliveras-Vergés and
Espel-Masferrer, 2008; Sackmann et al., 2009). Recently it was also found that the
transmembrane serine protease 6 (TMPRSS6) gene is important for the detection of iron
deficiency and for blocking HAMP transcription (Huang et al., 2008). There may exist other
pathways which regulate hepcidin and that are being investigated (Fleming, 2008; Nadadur et
al., 2008).
17
Iron and Infectious Diseases: the case of the Protozoa
In the same way that it is essential to humans, iron is fundamental to almost all living
organisms, and infectious agents, such as some protozoans, are no exception. An infectious
disease can be a very stressing event influencing the general homeostasis of the body
(including iron metabolism) by multiple mechanisms. These can be triggered both by the host
and by the infectious agent(s). In this context, defense strategies of our organism may consist
in modifications leading to the reduction of iron availability to invader pathogens. Therefore,
these can be as more virulent as the more capable they are of developing ways to acquire
necessary iron (León-Sicairos et al., 2005; Weinberg, 2009).
An adequate iron balance is relevant for all cells including those that participate in the
defense of our organism, and its impairment, particularly in iron-overloaded situations, may
compromise immunological pathways directed to the clearance of the pathogens (Weiss,
2005).
Monocytes and macrophages, key cells in iron metabolism (as discussed before), have an
important paper in fighting these threats. Their natural resistance associated macrophage
protein 1 (Nramp1) is associated to resistance against infection by certain intracellular
pathogens. Nramp1 belongs to the same family as DMT1 sharing 64% of the amino acid
sequence, is present in lysosomes and late endosomes but may be quickly recruited to
membranes of maturing phagosomes (Knutson and Wessling-Resnick, 2003; Weiss, 2005;
Huynh et al., 2006). Together with other strategies to keep off iron from intracellular
pathogens (particularly those mediated by INF-γ), Nramp1 (as a pH dependent divalent cation
efflux pump) may work to clear iron from infected phagolysosomes (Marquis and Gros, 2007;
Huynh and Andrews, 2008; Weinberg, 2009).
18
Although iron-mediated generation of toxic radicals can be harmful to human cells, they
can be used by neutrophils and macrophages / monocytes to kill pathogens (Weiss, 2005).
However, in excess, iron can be harmful to defense strategies of these cells (Weiss, 2005). As
an example, iron-loaded macrophages can experience impaired capacity to destroy
intracellular pathogens by INF-γ-mediated pathways (Theurl, 2005; Weiss, 2005). In this
case, iron may decrease generation of NO, an important molecule in macrophage defense
strategy (Theurl, 2005; Weiss, 2005).
An infectious process is generally accompanied by inflammation, which severity depends
on various factors both of the host and of the infectious agent. Inflammatory processes,
especially chronic ones, frequently lead to mild / moderate anemia that is, in part, due to
alterations in iron metabolism (Andrews, 2008; Friedman et al., 2009). These alterations
consist in hypoferremia (deficient iron supply to erythroid precursors) and, in contrast to iron
deficiency anemia, iron-binding capacity may be decreased (Weiss, 2005; Northrop-Clewes,
2008). Iron stores are usually normal or even elevated due, in part, to increased
erythrophagocytosis (Weiss, 2005; Northrop-Clewes, 2008). Mechanisms that explain
inflammatory-mediated changes in iron metabolism depend on a complex interaction of
cytokines, acute-phase proteins and radicals (Weiss, 2005; Northrop-Clewes, 2008). In this
process, it is important to highlight hepcidin, which expression is enhanced by inflammation
(as referred before), and α1-antitrypsin (α1-AT), another acute phase protein that competitively
blocks the binding of Tf to its receptor, affecting iron uptake by erythroid progenitor cells
(Theurl 2005; Weiss, 2005; Howard et al., 2007). Hence, inflammatory-mediated changes
may also limit iron availability to pathogens and strengthen cell-mediated immune effector
pathways (Theurl 2005; Weiss, 2005).
19
The iron-binding protein Lf is also an acute phase molecule and it is very important
because it has many immunoregulatory functions (Wilson and Britigan, 1998; Weiss, 2005).
As Tf or ferritin do (by chelating iron), Lf limits iron availability to infectious pathogens,
even in low pH sites, that can occur in an infectious process, which contrast to Tf that
liberates iron as soon as pH starts to decrease (Wilson and Britigan, 1998; Weinberg, 2009).
So, acquisition of iron in our organism is a real challenge to invader pathogens with many
barriers to be overcome.
In order to exemplify the importance of iron (and changes in its metabolism) in what
concern to infectious diseases in the human body, some aspects currently known or under
discussion will be now presented for some protozoan pathogens.
Entamoeba histolytica
This protozoan is an extracellular parasite that causes an intestinal and hepatic disease
usually denominated amoebiasis, which incidence is higher in most developing countries in
the tropics (Fauci et al., 2008). Its successful adaptation in the human body is partly related to
its capacity to acquire iron from several sources.
Entamoeba histolytica can internalize ferritin via clathrin-coated vesicles and holo-Lf
through a specific receptor-mediated endocytosis involving caveolae-like filipin-sensitive
vesicles which subsequently release iron in the acidic environment of amoebic vesicles with
participation of cysteine proteases (León-Sicairos et al., 2005; López-Soto et al., 2009). This
parasite has also the ability to acquire ionic iron, holo-Tf and Hb (Léon-Sicairos et al., 2005;
Cruz-Castañeda and Olivares-Trejo, 2008). In what concerns to Hb, two recent discovered
20
parasitic Hb-binding proteins – Ehhmbp45 and Ehhmbp26 – may play a role in its acquisition
(Cruz-Castañeda and Olivares-Trejo, 2008; Cruz-Castañeda et al., 2009). (Figure 2)
Figure 2. Iron sources for Entamoeba histolytica during its infection in the human body. This
range of iron sources seem to be advantageous to Entamoeba histolytica. This parasite may use holo-
Lf and Hb as iron sources during the infection in intestinal mucosa, while the same is true for holo-Tf
(and Hb) when the parasite reaches the blood and, in the liver, ferritin may become of higher
importance to its adaptation.
One of the reasons why iron is indispensable for Entamoeba histolytica survival is because
the enzyme EhADH2 (alcohol dehydrogenase 2), a key on the parasite’s energy metabolism,
requires Fe2+
as a cofactor (Espinosa et al., 2009). It was suggested that iron may play an
important role in virulence of this protozoan, by modulation of the expression of genes related
to adherence and cytotoxicity (Lee et al., 2008). Not surprisingly, it was reported that low-
21
iron-content diets may confer a certain degree of resistance to amoebiasis, what suggests that
iron-starvation-based therapies like, for example, iron chelation, may become important in
amoebiasis treatment in the future (Espinosa et al., 2009).
Leishmania
Several species of Leishmania, spread in many countries worldwide, cause a wide
spectrum of clinical disease that range from “benign” cutaneous lesions to potential life-
threatening visceralization (Huynh et al., 2006; Marquis and Gros, 2007; Fauci et al., 2008).
In severe visceral leishmaniasis, anemia usually develops and bleeding can also occur (Fauci
et al., 2008). There are two forms of this parasite: the promastigote, transmitted by the bite of
phlebotomine, and the amastigote, the main form in the human host, found inside macrophage
phagolysosomes (Fauci et al., 2008; Das et al., 2009).
Iron is vital for Leishmania, being necessary for its basic metabolic activity and essential
for the function of important enzymes such as the metalloenzyme superoxide dismutase
(SOD) and ribonucleotide reductase (RR) (Sen et al., 2008; Huynh and Andrews, 2008; Das et
al., 2009). SOD has a protective role by detoxifying O2-, which is important for resistance to
oxidative stress, while RR is critical for DNA synthesis (Sen et al., 2008; Huynh and
Andrews, 2008).
It was found that Leishmania can acquire iron from several sources, but Fe2+
acquisition
strategies seem to be of particular importance, at least, for the intracellular amastigote form
(Huynh et al., 2006; Sutak et al., 2008). These parasites can take up holoTf and holoLf,
although the respective mechanisms need to be better elucidated (Wilson and Britigan, 1998;
Huynh et al., 2006). It was also detected in Leishmania donovani promastigotes and in
22
Leishmania infantum amastigostes a specific receptor involved in Hb endocytosis
(Krishnamurthy et al., 2005; Carvalho et al., 2009). Evidence for receptor-mediated uptake of
heme also exists, both for Leishmania mexicana promastigotes and Leishmania infantum
amastigotes (Wilson and Britigan, 1998; Carvalho et al., 2009). A recently identified ferrous
iron transporter, LIT-1, present in the membrane of Leishmania amazonensis was reported to
participate in uptake of Fe2+
by intracellular amastigotes, being expressed particularly in iron
starving conditions (Huynh et al., 2006). Nevertheless, LIT-1 is essential for Leishmania
amazonensis virulence but not for its survival (Huynh et al, 2006). It also seems that a single
integral membrane ferric reductase exists in Leishmania major, Leishmania infantum and
Leishmania braziliensis (Huynh and Andrews, 2008). There are reports suggesting that
expression of DMT1 and Nramp1 in the endosomal pathway (as discussed before) may result
in small amounts of the metal available to the parasite (Huynh et al., 2006; Huynh and
Andrews, 2008). This could constitute a challenge to Leishmania parasites, although this is
still an area without consensus. It may occur that Nramp1 may affect the parasite by
mechanisms unrelated to nutritional reasons (Gomez et al., 2007). It is possible that depletion
of ionic iron is partly overcome by the uptake of other sources of iron, like heme and Hb,
which may fulfill some of the parasite requirements (Carvalho et al., 2009). Recently, Das et
al. (2009) demonstrated that intracellular Leishmania donovani is able to deplete the
macrophage labile iron pool as a strategy to acquire iron and that this iron pool might be
successively renovated by induction of the expression of TfR1, with impaired ferritin
synthesis; the ability to increase TfR1 expression was corroborated in Leishmania major.
To obtain a complete picture of the iron-acquisition strategies (and their importance)
present in Leishmania more research is necessary, although, what is known, helps in the
23
comprehension of virulence mechanisms of these parasites and points towards possible
therapeutic targets such as the transporter LIT-1.
Malaria
Malaria is an important factor of morbidity and mortality, especially in endemic areas, that
are mainly located in the tropical regions. It is caused by protozoa of the genus Plasmodium,
being Plasmodium falciparum the etiologic agent responsible for the most severe cases.
During infection, parasites invade erythrocytes and, in some cases, reticulocytes. Hb, as a
source of aa, is very important for the parasite. It undergoes endocytosis and is degraded in
the acidic environment of the food vacuole that contains Asp and Cys proteases; part of the
resulting heme originates hemozoin, the “malaria pigment”, while a small amount may exit
the food vacuole to be degraded in the parasite cytosol via glutathione (Wilson and Britigan,
1998; Cabantchik et al., 1999). Hemozoin was considered an inert material, but its biological
activity is becoming apparent, for example, in what concerns to its role in catalyzing the
formation of free radicals and even its contribution in the pathogenesis of malarial anemia
(Gosh and Gosh, 2007).
Iron is important for the growth of malaria parasites but its main source to the parasite
remains unclear (Prentice, 2008). It is debatable whether a Tf-dependent process to acquire
this metal does exist in these parasites, with some authors defending that parasites insert Tf-
like receptors on the host erythrocyte membrane (Wilson and Britigan, 1998; Gosh and Gosh,
2007). An iron-regulated IRP-like protein was found in Plasmodium falciparum but it is
unclear whether it plays any role in parasite iron homeostasis (Loyevski et al., 2001).
24
Anemia is a common finding in malaria and may be the result of several mechanisms still
not completely understood such as, for example, hemolysis and inflammatory mediated
pathways (Gosh and Gosh, 2007; Ndyomugyenyi et al., 2008; Northrop-Clewes, 2008).
Indeed, the levels in sera of mediators related to inflammation are found to be raised in
malaria. This is the case of IL-6 and, as discussed before, this may constitute a defense
strategy against the parasite (Gosh and Gosh, 2007; Howard et al., 2007). In this context,
some hypothesis can be made and shall be tested, like the one presented by Oliveras-Vergés
and Espel-Masferrer (2007), which suggests a protective role of hepcidin against malaria
sporozoites in the liver through decreasing the availability of Ca2+
. In a study with Ghana
patients with malaria due to Plasmodium falciparum, an association between the
concentration of urinary hepcidin and parasitemia was found, with high levels of urinary
hepcidin corresponding to patients with high levels of parasitemia (Howard et al., 2007).
Iron metabolism in the host and treatments that affect the iron load of the body may
influence the course of malarial infection, as many studies about this subject report.
Iron deficiency may be beneficial against malaria and there are some studies supporting
this principle. For example, a study with mice, reported that iron-deficiency improves the
course of malaria, one reason being because it enhances clearance of infected erythrocytes
(Koka et al, 2007). A protective effect of iron deficiency to placental malaria in women and to
clinical malaria in children was also reported (Kabyemela et al., 2008; Friedman et al., 2009).
These findings might be explained by a lower iron availability to the parasite or by
strengthening of immune effector pathays such as generation of NO by macrophages
(Kabyemela et al., 2008; Friedman et al., 2009) (as already referred).
Although, in theory, one would think that iron supplementation / iron-rich diet has
detrimental effects on malaria outcomes and would increase susceptibility to this disease, not
25
all studies supported this hypothesis (Cabantchik et al., 1999; Mebrahtu et al., 2004; Richard
et al., 2006; Kabyemela et al., 2008; Prentice, 2008; Weinberg, 2009; Friedman et al., 2009).
These contradictory findings may have several explanations and variables such as health care
facilities, body iron status or acquired immunity may affect the results of the studies.
However, this field needs to be better clarified in order to devise strategies that can improve
health of populations living in endemic areas where malarial anemia and iron deficiency
anemia coexist and are prevalent, particularly in childhood and pregnancy.
In a study with Zambian children infected with Plasmodium falciparum that suffered from
its most feared complication, cerebral malaria, it was observed an improved parasite clearance
when the iron chelator desferrioxamine was administered additionally to the standard
treatment. In particular, deep coma recovery enhanced with the chelator. A subsequent
retrospective analysis of Tf saturations in these children supported the hypothesized role of
iron-generated free radicals in the pathogenesis of this kind of coma because recovery, using
the iron chelator, seemed to be specifically improved in children with high Tf saturations
(Cabantchik et al., 1999). Although this iron chelation treatment may have beneficial effects
on morbidity, the same does not seem to be true in what concerns to mortality which can even
be higher (Cabantchik et al., 1999). Other clinical studies with desferrioxamine were
preformed and showed beneficial effects on Plasmodium parasitemia, at least in a short period
of time (Cabantchik et al., 1999). Nevertheless, more research in this field is necessary to
support a clinical use of iron chelators as anti-malarials. Namely, it is important the
production and discovery of new substances characterized by higher efficacy and well
tolerability, with minimal adverse effects on the patient.
26
Trichomonas vaginalis
Trichomonas vaginalis, the etiologic agent of the worldwide sexual transmitted disease
trichomoniasis, usually resides in the urogenital cavities, particularly in the vagina (Jesus et
al., 2006).
The adaptability of Trichomonas vaginalis to its habitat may be explained by its capacity to
use several sources of iron. HoloLf is one of the vaginal iron sources for this parasite, that
possesses a specific receptor for it which expression and affinity are increased in iron-
depleted medium (Wilson and Britigan, 1998; León-Sicairos et al., 2005). Also, the iron
requirements of Trichomonas vaginalis can be satisfied by phagocytosis of erythrocytes
(particularly during menstruation) and it seems that the adhesion proteins AP51 and AP65
have a role in iron uptake, because they may have heme and Hb-binding properties (Ardalan
et al., 2009).
There are a number of studies about the influence of iron in Trichomonas vaginalis and
growing evidence suggests it affects the virulence of this parasite. In fact, the expression of
several proteins of this parasite was found to be modulated by iron although the underlying
mechanisms are only starting to be understood (Jesus et al., 2007). An iron-responsive
promoter was reported to be present in the ap65-1 gene and an identified IRP/IRE-like system
could regulate expression of the cysteine proteinase TVCP4 (Tsai et al., 2002; Solano-
González et al., 2007). Some proteins were found to be enhanced and others decreased by
similar iron conditions, what is possibly related to the necessity of the parasite to adapt to
changes in the environment as occurs with the menstrual cycle. Some adhesin molecules and
TV44 (an IgA-reactive surface protein) are examples of proteins which expression is
decreased (or even suppressed) in low-iron media (Moreno-Brito et al., 2005; Mundodi et al.,
2006). Also, ecto-phosphatase and ecto-ATPase activities are reduced under iron-depleted
27
conditions (Jesus et al., 2006). On the contrary, for instance, the activity of cysteine proteases
CP30 and CP65 (proteins that are related to cytotoxicity) is induced (Alvarez-Sánchez et al.,
2007; Kummer et al., 2008). The activity of hydrogenosomes (an organelle related with
energy metabolism and drug susceptibility) appear to be also regulated by iron (Kim et al.,
2006). Interestingly, when the iron-content of the medium is reduced morphological changes
can occur in the parasite which adopts a pseudocyst form (Jesus et al., 2007). To conclude,
further research is required to clarify all these findings and their importance for the in vivo
infection and also to characterize other possible mechanisms and proteins which function in
iron metabolism of this parasite.
Trypanosoma
Parasites from the genus Trypanosoma are an important cause of morbidity and mortality,
namely Trypanosoma cruzi, the etiologic agent of Chagas disease, and Trypanosoma brucei
ghambiense and Trypanosoma brucei rhodesiense, the etiologic agents of sleeping sickness,
being the first one endemic in America and the others in Africa (Fauci et al., 2008). Also for
these parasites, iron is an essential element, as anti-trypanosomal effects of iron chelators
suggest (Merschjohann and Steverding, 2006). Nevertheless, there is less information
available related to iron for Trypanosoma cruzi than for Trypanosoma brucei subspecies.
Trypanosoma brucei lives in the blood and acquires most of its iron from Tf. It presents
receptors for Tf, which enable acquisition of this iron source, because their expression is
increased in iron starvation conditions (Mussmann et al., 2004; Steverding, 2006).
During the course of African trypanosomiasis, the inflammatory environment can lead to
anemia. A performed study with an experimental Trypanosoma brucei infection in a murine
28
model reinforced the notion that iron sequestration in activated macrophages is enhanced
during the chronic phase of trypanosomiasis (Stijlemans et al., 2008). The same report
suggests that, in the acute phase of infection, an increase in iron recycling may become
favorable for iron acquisition by the parasite.
Brief notes regarding other Protozoa
Intraerythrocytic protozoa from the genus Babesia have animals as natural reservoirs but
have been responsible for some cases of infection in humans (reported worldwide), being
transmitted by ectoparasites from the genus Ixodes. The disease can vary from a mild flulike
syndrome to a malaria-like one, with the possibility to be life threatening. The severity of the
process depends also on host factors such as age or immunity for example. Hemolytic anemia
can occur, with the subsequent formation of haptoglobin-Hb complexes in the circulation and
iron may be lost through hemoglobinuria. (Fauci et al., 2008)
The relationship of Blastocystis hominis with iron metabolism is poorly studied and several
questions persist in what concern to its pathogenic mechanisms. It seems that when this
protozoan parasites intestinal tract it may contribute to the generation of iron deficiency
anemia (Yavasoglu et al., 2008).
Giardia lamblia, a flagellate intestinal protozoan, is the etiological agent of widespread
giardiasis. Giardiasis, particularly symptomatic one, usually course with malabsorption of
duodenum and proximal jejunum, due to diffuse reduction in the microvillus surface area by
the parasite, a process that can result in decreased ferremia and evolve to iron deficiency
anemia (Ertan et al., 2002; Monajemzadeh and Monajemzadeh, 2008; Kasirga et al., 2009). Lf
29
may play a role in the resistance to Giardia lamblia because, in vitro, it was found to be
cytotoxic for trophozoites (the active form of the parasite) (Wilson and Britigan, 1998).
Toxoplasma gondii, an obligate intracellular parasite, is the etiologic agent of
toxoplasmosis and may be responsible for several clinical manifestations, particularly in
congenital infection and in immunocompromised patients. In this infection, iron losses can be
increased, for example via hemoptysis which can coexist with pneumonia. (Fauci et al., 2008)
In studies with Toxoplasma gondii-infected human fibroblasts an increased activity of
IRP1 was reported, with subsequent up-regulation of TfR1. The mechanism responsible for
this finding appeared to be related with secreted factor(s) that need further research. (Gail et
al., 2004)
Conclusion
Iron is essential and plays important rules in the human host and also in protozoan parasite
which usually leads to a competition for this element during an infectious process. In our
organism, iron homeostasis is achieved mainly with regulation at the level of intestinal
absorption, because there are no active pathways for excretion of iron, and at the level of its
releasing from the storage compartment, where macrophage plays a central rule. The
discovery of hepcidin and its role on systemic iron regulation answered many questions about
the regulation of iron metabolism in our organism. A virulence factor of protozoans often
consists on the development of strategies to acquire iron, evading iron withholding strategies
of the host, such as the existence of receptors for iron containing compounds that usually exist
in the host environment, for example.
30
In spite of the existence of some protozoans where this subject is poorly studied, like the
case of Trypanosoma cruzi, therapeutical strategies such those aimed at preventing iron access
to the parasites may be promising. However, as happens with many other therapeutic
strategies in several pathologic situations, the risk of adverse effects exist, at least because
iron is also essential to our organism and because the possibility of drugs against parasite
molecules interact with host molecules is not disposable.
Further research is necessary to illuminate unanswered questions related to these subjects
and ideally many of those should be investigated in vivo (including, in some circumstances, in
humans), respecting, of course, ethic imperatives.
Acknowledgments
This work was supervised by Professor Ana Tomás (University of Porto) and by Professor
Anabela Mota Pinto (University of Coimbra) to whom the Author sincerelly thanks.
REFERENCES
Alvarez-Sánchez ME, Solano-González E, Yañez-Gómez C, Arroyo R (2007) Negative
iron regulation of the CP65 cysteine proteinase cytotoxicity in Trichomonas vaginalis.
Microbes Infect 9:1597-1605
Andrews NC (2008) Forging a field: the golden age of iron biology. Blood 112(2):219-230
Ardalan S, Lee BC, Garber GE (2009) Trichomonas vaginalis: The adhesions AP51 and
AP65 bind heme and hemoglobin. Exp Parasitol 121:300-306
31
Bou-Abdallah F, Zhao G, Biasiotto G, Poli M, Arosio P, Chasteen ND (2008) Facilitated
Diffusion of Iron(II) and Dioxygen Substrates into Human H-Chain Ferritin. A Fluorescence
and Absorbance Study Employing the Ferroxidase Center Substitution Y34W. J Am Chem
Soc 130(52):17801-17811
Cabantchik ZI, Moody-Haupt S, Gordeuk VR (1999) Iron chelators as anti-infectives; malaria
as a paradigm. FEMS Immunol Med Microbiol 26:289-298
Carvalho S, Cruz T, Santarém N, Castro H, Costa V, Tomás AM (2009) Heme as a source of
iron to Leishmania infantum amastigotes. Acta Trop 109:131-135
Collins JF, Wessling-Resnick M, Knutson MD (2008) Hepcidin Regulation of Iron Transport.
J Nutr 138:2284-2288
Cruz-Castañeda A, Olivares-Trejo JJ (2008) Ehhmbp45 is a novel hemoglobin-binding
protein identified in Entamoeba histolytica. FEBS Lett 582:2806-2810
Cruz-Castañeda A, Hernández-Sánchez J, Olivares-Trejo JJ (2009) Cloning and identification
of a gene coding for a 26-kDa hemoglobin-binding protein from Entamoeba histolytica.
Biochimie 91:383-389
Das NK, Biswas S, Solanki S, Mukhopadhyay (2009) Leishmania donovani depletes labile
iron pool to exploit iron uptake capacity of macrophage fot its intracellular growth. Cell
Microbiol 11(1):83-94
Dos Santos CO, Dore LC, Valentine E, Shelat SG, Hardison RC, Ghosh M, et al (2008) An
Iron Responsive Element-Like Stem-Loop Regulates Alpha Hemoglobin Stabilizing Protein
mRNA. J Biol Chem 283(40):26956-26964
32
Edison ES, Bajel A, Chandy M (2008) Iron homeostasis: new players, newer insights. Eur J
Haematol 81(6):411-424
Ertan P, Yereli K, Kurt O, Balcioglu IC, Onag A (2002) Serological levels of zinc, copper and
iron elements among Giardia lamblia infected children in Turkey. Pediatr Int 44:286-288
Espinosa A, Perdrizet G, C. GP, Lanfranchi R, Phay M (2009) Effects of iron depletion on
Entamoeba histolytica alcohol dehydrogenase 2 (EhADH2) and trophozoite growth:
implications for antiamoebic therapy. J Antimicrob Chemother 63:675-678
Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, et al (2008)
Harrison’s Principles of Internal Medicine. 17th Edition. USA: McGraw-Hill
Fleming MD (2008) The Regulation of Hepcidin and Its Effects on Systemic and Cellular
Iron Metabolism. Hematology Am Soc Hematol Educ Program 151-158
Friedman JF, Kurtis JD, Kabyemela ER, Fried M, Duffy PE (2009) The iron trap: Iron,
malaria and anemia at the mother-child interface. Microbes Infect 11(4):460-466
Gail M, Gross U, Bohne W (2004) Transferrin receptor induction in Toxoplasma gondii-
infected HFF is associated with increased iron-responsive protein 1 activity and is mediated
by secreted factors. Parasitol Res 94:233-239
Ghosh K, Ghosh K (2007) Pathogenesis of anemia in malaria: a concise review. Parasitol Res
101:1463-1469
Gomez MA, Li S, Tremblay ML, Olivier M (2007) NRAMP-1 expression modulates protein-
tyrosine phosphatase activity in macrophages: impact on host cell signaling and functions. J
Biol Chem 282(50):36190-36198
33
Howard CT, McKakpo US, Quakyi IA, Bosompem KM, Addison EA, Sun K, et al (2007)
Relationship of Hepcidin with Parasitemia and Anemia among Patients with Uncomplicated
Plasmodium falciparum Malaria in Ghana. Am J Trop Med Hyg 77(4):623-626
Huang X, Fung ET, Yip C, Zeleniuch-Jacquotte A (2008) Serum prohepcidin is associated
with soluble transferrin receptor-1 but not ferritin in healthy post-menopausal women. Blood
Cells Mol Dis 41:265-269
Huynh C, Sacks DL, Andrews NW (2006) A Leishmania amazonensis ZIP family iron
transporter is essential for parasite replication within macrophage phagolysosomes. J Exp
Med 203(10):2363-2375
Huynh C, Andrews NW (2008) Iron acquisition within host cells and the pathogenicity of
Leishmania. Cell Microbiol 10(2):293-300
Jesus JB, Cuervo P, Junqueira M, Britto C, Silva-Filho FC, Soares MJ, et al (2007) A further
proteomic study on the effect of iron in the human pathogen Trichomonas vaginalis.
Proteomics 7:1961-1972
Jesus JB, Ferreira MA, Cuervo P, Britto C, Silva-Filho FC, Meyer-Fernandes JR (2006) Iron
modulates ecto-phosphohydrolase activities in pathogenic trichomonads. Parasitol Int 55:285-
290
Kabyemela ER, Fried M, Kurtis JD, Mutabingwa TK, Duffy PE (2008) Decreased
Susceptibility to Plasmodium falciparum Infection in Pregnant Women with Iron Deficiency.
J Infect Dis 198:163-6
34
Kasirga E, Gulen H, Simsek A, Ayhan S, Yilmaz O, Ellidokuz E (2009) Coexistence of
Symptomatic Iron-Deficiency Anemia and Duodenal Nodular Lymphoid Hyperplasia due to
Giardiasis: Case Report. Pediatr Hematol Oncol 26(1):57-61
Kemna EHJM, Tjalsma H, Willems HL, Swinkels DW (2008) Hepcidin: from discovery to
differential diagnosis. Haematologica 93(1):90-97
Kim Y, Song H, Choi I, Park S, Ryu J (2006) Hydrogenosomal activity of Trichomonas
vaginalis cultivated under different iron conditions. Korean J Parasitol 44(4):373-378
Koka S, Föller M, Lamprecht G, Boini KM, Lang C, Huber SM, et al (2007) Iron deficiency
influences the course of malaria in Plasmodium berghei infected mice. Biochem Biophys Res
Commun 357:608-614
Knutson M, Wessling-Resnick M (2003) Iron Metabolism in the Reticuloendothelial System.
Crit Rev in Biochem Mol Biol 38(1):61-88
Krishnamurthy G, Vikram R, Singh SB, Patel N, Agarwal S, Mukhopadhyay G, et al (2005)
Hemoglobin Receptor in Leishmania is a Hexokinase Located in the Flagellar Pocket. J Biol
Chem 280(7):5884-5891
Kummer S, Hayes GR, Gilbert RO, Beach DH, Lucas JJ, Singh BN (2008) Induction of
human host cell apoptosis by Trichomonas vaginalis cysteine proteases is modulated by
parasite exposure to iron. Microb Pathog 44:197-203
Lee J, Park S, Yong T (2008) Effect of Iron on Adherence and Cytotoxicity of Entamoeba
histolytica to CHO Cell Monolayers. Korean J Parasitol 46(1):37-40
35
León-Sicairos N, Reyes-López M, Canizalez-Román A, Bermúdez-Cruz RM, Serrano-Luna J,
Arroyo R (2005) Human hololactoferrin: endocytosis and use as an iron source by the parasite
Entamoeba histolytica. Microbiology 151:3859-3871
López-Soto F, González-Robles A, Salazar-Villatoro L, León-Sicairos N, Piña-Vázquez C,
Salazar EP, et al (2009) Entamoeba histolytica uses ferritin as an iron source and internalises
this protein by means of clathrin-coated vesicles. Int J Parasitol 39:417-426
Loyevski M, LaVaute T, Allerson CR, Stearman R, Kassim OO, Cooperman S, et al (2001)
An IRP-like protein from Plasmodium falciparum binds to a mammalian iron-responsive
element. Blood 98:2555-2562
Marquis J, Gros P (2007) Intracellular Leishmania: your iron or mine? Trends Microbiol
15(3):93-95
Mebrahtu T, Stoltzfus RJ, Chwaya HM, Jape JK, Savioli L, Montresor A, et al (2004) Low-
Dose Daily Iron Supplementation for 12 Months Does Not Increase the Prevalence of
Malarial Infection or Density of Parasites in Young Zanzibari Children. J Nutr 134:3037-3041
Merschjohann K, Steverding D (2006) In vitro growth inhibition of bloodstream forms of
Trypanosoma brucei and Trypanosoma congolense by iron chelators. Kinetoplastid Biol Dis
5:3
Monajemzadeh SM, Monajemzadeh M (2008) Comparison of iron and hematological indices
in Giardia lamblia infection before and after treatment in 102 children in Ahwaz, Iran. Med
Sci Monit 14(1):CR19-23
Moreno-Brito V, Yáñez-Gómez C, Meza-Cervantez P, Ávila-González L, Rodríguez MA,
Ortega-López J, et al (2005) A Trichomonas vaginalis 120 kDa protein with identity to
36
hydrogenosome pyruvate:ferredoxin oxidoreductase is a surface adhesin induced by iron. Cell
Microbiol 7(2):245-258
Mundodi V, Kucknoor AS, Chang T-H, Alderete JF (2006) A novel surface protein of
Trichomonas vaginalis is regulated independently by low iron and contact with vaginal
epithelial cells. BMC Microbiol 6:6
Mussmann R, Engstler M, Gerrits H, Kieft R, Toaldo CB, Onderwater J, et al (2004) Factors
Affecting the Level and Localization of the Transferrin Receptor in Trypanosoma brucei. J
Biol Chem 279(39):40690-40698
Nadadur SS, Srirama K, Mudipalli A (2008) Iron transport & homeostasis mechanisms: Their
role in health & disease. Indian J Med Res 128:533-544
Ndyomugyenyi R, Kabatereine N, Olsen A, Magnussen P (2008) Malaria and hookworm
infections in relation to haemoglobin and serum ferritin levels in pregnancy in Masindi
district, western Uganda. Trans R Soc Trop Med Hyg 102:130-136
Northrop-Clewes CA (2008) Interpreting indicators of iron status during an acute phase
response – lessons from malaria and human immunodeficiency virus. Ann Clin Biochem
45:18-32
Oliveras-Vergés A, Espel-Masferrer E (2008) Elevated basal hepcidin levels in the liver may
inhibit the development of malaria infection: Another piece towards solving the malaria
puzzle? Med Hypotheses 70:630-634
Paradkar PN, Zumbrennen KB, Paw BH, Ward DM, Kaplan J (2009) Regulation of
Mitochondrial Iron Import through Differential Turnover of Mitoferrin 1 and Mitoferrin 2.
Mol Cell Biol 29(4):1007-1016
37
Prentice AM (2008) Iron Metabolism, Malaria, and Other Infections: What Is All the Fuss
About? J Nutr 138:2537-2541
Rhodes SL, Ritz B (2008) Genetics of iron regulation and the possible role of iron in
Parkinson’s disease. Neurobiol Dis 32:183-195
Richard SA, Zavaleta N, Caulfield LE, Black RE, Witzig RS, Shankar AH (2006) Zinc and
Iron Supplementation and Malaria, Diarrhea, and Respiratory Infections in Children in the
Peruvian Amazon. Am J Trop Med Hyg 75(1):126-132
Sackmann A, Formanowicz D, Formanowicz P, Blazewicz J (2009) New insights into the
human body iron metabolism analyzed by a Petri net based approach. BioSystems 96(1):104-
113
Schaer CA, Schoedon G, Imhof A, Kurrer OM, Schaer DJ (2006) Constitutive Endocytosis of
CD163 Mediates Hemoglobin-Heme Uptake and Determines the Noninflammatory and
Protective Transcriptional Response of Macrophages to Hemoglobin. Circ Res 99:943-950
Schaer CA, Vallelian F, Imhof A, Schoedon G, Schaer DJ (2008) Heme carrier protein (HCP-
1) spatially interacts with the CD163 hemoglobin uptake pathway and is a target of
inflammatory macrophage activation. J Leukoc Biol 83:325-333
Schulze KJ, Christian P, Ruczinski I, Ray AL, Nath A, Wu LS, et al (2008) Hepcidin and iron
status among pregnant women in Bangladesh. Asia Pac J Clin Nutr 17(3):451-456
Sen G, Mukhopadhyay S, Ray M, Biswas T (2008) Quercetin interferes with iron metabolism
in Leishmania donovani and targets ribonucleotide reductase to exert leishmanicidal activity.
J Antimicrob Chemother 61:1066-1075
Skikne BS (2008) Serum transferrin receptor. Am J Hematol 83:872-875
38
Solano-González E, Burrola-Barraza E, León-Sicairos C, Avila-González L, Gutiérrez-
Escolano L, Ortega-López J, et al (2007) The trichomonad cysteine proteinase TVCP4
transcript contains an iron-responsive element. FEBS Lett 581:2919-2928
Steverding D (2006) On the significance of host antibody response to the Trypanosoma brucei
transferrin receptor during chronic infection. Microbes Infect 8:2777-2782
Stijlemans B, Vankrunkelsven A, Brys L, Magez S, Baetselier P (2008) Role of iron
homeostasis in trypanosomiasis-associated anemia. Immunobiology 213:823-835
Subramaniam VN (2009) Regulation of Iron Homeostasis: is it all in the HBD?
Gastroenterology 136(4):1449-1451
Sutak R, Lesuisse E, Tachezy J, Richardson R (2008) Crusade for iron: iron uptake in
unicellular eukaryotes and its significance for virulence. Trends Microbiol 16(6):261-268
Swinkels DW, Janssen MCH, Bergmans J, Marx JJM (2006) Hereditary Hemochromatosis:
Genetic Complexity and New Diagnostic Approaches. Clin Chem 52(6): 950-968
Taketani S (2005) Acquisition, Mobilization and Utilization of Cellular Iron and Heme:
Endless Findings and Growing Evidence of Tight Regulation. Tohoku J Exp Med 205(4):297-
318
Theurl I, Fritsche G, Ludwiczek S, Garimorth K, Bellmann-Weiler R, Weiss G (2005) The
macrophage: A cellular factory at the interphase between iron and immunity for the control of
infections. BioMetals 18:359-367
Tsai CD, Liu HW, Tai JH (2002) Characterization of an Iron-responsive Promoter in the
Protozoan Pathogen Trichomonas vaginalis. J Biol Chem 277(7):5153-5162
Weinberg ED (2009) Iron availability and infection. Biochim Biophys Acta 1790(7):600-605
39
Weiss G (2005) Modification of iron regulation by the inflammatory response. Best Pract Res
Clin Haematol 18(2):183-201
West AR, Oates PS (2008) Mechanisms of heme iron absorption: Current questions and
controversies. World J Gastroenterol 14(26):4101-4110
Wilson ME, Britigan BE (1998) Iron Acquisition by Parasitic Protozoa. Parasitol Today
14(9):348-353
Yavasoglu I, Kadikoylu G, Uysal H, Ertug S, Bolaman Z (2008) Is Blastocystis hominis a new
etiological factor or a coincidence in iron deficiency anemia? Eur J Haematol 81(1):47-50
40